2017
DOI: 10.1186/s12885-017-3047-5
|View full text |Cite
|
Sign up to set email alerts
|

Lung cells support osteosarcoma cell migration and survival

Abstract: BackgroundOsteosarcoma (OS) is the most common primary bone tumor, with a propensity to metastasize to the lungs. Five-year survival for metastatic OS is below 30%, and has not improved for several decades despite the introduction of multi-agent chemotherapy. Understanding OS cell migration to the lungs requires an evaluation of the lung microenvironment. Here we utilized an in vitro lung cell and OS cell co-culture model to explore the interactions between OS and lung cells, hypothesizing that lung cells woul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(19 citation statements)
references
References 26 publications
(27 reference statements)
1
17
0
Order By: Relevance
“…4 A considerable proportion of patients already exhibit metastasis at the time of diagnosis, and the most frequent target organ of metastasis is lung. 5,6 The subsequent respiratory impairment is a leading cause of the death of OS patients. 7 These lung-metastasis OS patients have the poorest overall prognosis, with only a 19% five-year survival rate.…”
Section: Introductionmentioning
confidence: 99%
“…4 A considerable proportion of patients already exhibit metastasis at the time of diagnosis, and the most frequent target organ of metastasis is lung. 5,6 The subsequent respiratory impairment is a leading cause of the death of OS patients. 7 These lung-metastasis OS patients have the poorest overall prognosis, with only a 19% five-year survival rate.…”
Section: Introductionmentioning
confidence: 99%
“…Osteosarcoma is the most common primary bone tumor in young adults [1,2] and frequently occurs in the femur (42%), tibia (19%), and humerus (10%) [3]. Since the 1970s, despite the use of multi-agent chemotherapy and improvement in surgical techniques, the 5-year overall survival rate of osteosarcoma remains approximately 60% [4].…”
Section: Introductionmentioning
confidence: 99%
“…However, in the hydrogels with the same stiffness, positive staining and cell numbers varied little with the change in the density of adhesion ligands. ALDH plays a vital role in clinical osteosarcoma metastasis[24], and CD133 is also an osteosarcoma marker of metastasis and invasion[33, 34]. As shown in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The activity of ALDH that is a marker for the malignancy of osteosarcoma [24] was tested. Briefly, after intrascaffold cultured for 7 days, the cell-gel composites of osteosarcoma were first placed on ice then ALDH was detected by an ALDH test kit (Solarbio, Beijing, China) as indicated by the manufacturer.…”
Section: Methodsmentioning
confidence: 99%